CAH - Cardinal Health - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082

Pharmaceuticals, Medical Supplies, Surgical Products, Gloves, Needles, Syringes

Cardinal Health Inc. is a leading healthcare services and products company that operates globally, with a presence in the United States, Canada, Europe, Asia, and other international markets. The company provides tailored solutions to a wide range of healthcare providers, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients receiving care in their homes.

Cardinal Health's business is divided into two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company distributes a vast array of products, including branded and generic pharmaceuticals, specialty pharmaceuticals, over-the-counter healthcare products, and medical supplies. Additionally, it offers specialized services to pharmaceutical manufacturers and healthcare providers, such as pharmacy management services to hospitals and repackaging of generic pharmaceuticals and over-the-counter healthcare products.

In the medical products space, Cardinal Health designs, manufactures, sources, and distributes a broad portfolio of Cardinal Health branded products, including exam and surgical gloves, needles, syringe, and sharps disposals, compression solutions, incontinence products, nutritional delivery systems, wound care products, and more. The company also distributes a range of national brand products, including medical, surgical, and laboratory products, and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers.

Furthermore, Cardinal Health assembles and sells sterile and non-sterile procedure kits, and manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments. The company also leverages its integrated technology solutions to optimize direct shipments and streamline logistics for its customers.

Founded in 1979, Cardinal Health is headquartered in Dublin, Ohio, and has established itself as a trusted partner to healthcare providers around the world. With a strong commitment to improving patient care and outcomes, the company continues to innovate and expand its offerings to meet the evolving needs of the healthcare industry.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for CAH - Cardinal Health  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for CAH - Cardinal Health  - Stock Price & Dividends

CAH Stock Overview

Market Cap in USD 26,957m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1987-12-31

CAH Stock Ratings

Growth 5y 86.5
Fundamental 43.5
Dividend 52.0
Rel. Performance vs Sector -0.34
Analysts 3.44/5
Fair Price Momentum 123.17 USD
Fair Price DCF 335.19 USD

CAH Dividends

Dividend Yield 12m 1.80%
Yield on Cost 5y 5.14%
Dividends CAGR 5y 0.80%
Payout Consistency 95.5%

CAH Growth Ratios

Growth 12m 26.93%
Growth Correlation 12m 27%
Growth Correlation 3m 84%
CAGR 5y 23.33%
CAGR/Mean DD 5y 2.86
Sharpe Ratio 12m 1.04
Alpha vs SP500 12m -2.80
Beta vs SP500 5y weekly 0.82
ValueRay RSI 56.74
Volatility GJR Garch 1y 19.51%
Price / SMA 50 3.91%
Price / SMA 200 7.97%
Current Volume 1490.7k
Average Volume 20d 1992.1k

External Links for CAH Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of CAH stocks?
As of October 05, 2024, the stock is trading at USD 111.98 with a total of 1,490,687 shares traded.
Over the past week, the price has changed by +2.46%, over one month by -1.24%, over three months by +17.32% and over the past year by +25.81%.
What are the forecast for CAH stock price target?
According to ValueRays Forecast Model, CAH Cardinal Health will be worth about 134.5 in October 2025. The stock is currently trading at 111.98. This means that the stock has a potential upside of +20.15%.
Issuer Forecast Upside
Wallstreet Target Price 117.4 4.85
Analysts Target Price 98.6 -12.0
ValueRay Target Price 134.5 20.1